KVS0001
Pre-clinical- Indications
- Brain cancer, Spinal cord cancer
Company intelligence / Profile preview
Belay Diagnostics
Chicago, Illinois, United Statesbelaydiagnostics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Belay Diagnostics has developed proprietary, clinically validated liquid biopsy assays—Summit™ and Vantage™—for the minimally invasive detection and genomic characterization of brain and spinal cord cancers using patient cerebrospinal fluid. These tests are designed to improve diagnostic accuracy while reducing the need for risky surgical biopsies. The technology builds on research from Johns Hopkins University. Clinical results indicate high sensitivity/specificity compared to traditional cytology or tissue biopsy methods.
No therapeutic trials; focus on diagnostics.
- Therapeutic areas
- Oncology
- Modalities
- Molecular diagnostics (liquid biopsy using cerebrospinal fluid)
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
GenomOncology (bioinformatics/data analysis partnership)
Beyond the preview
Go deeper on Belay Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belay Diagnostics.